InvestorsHub Logo
Followers 72
Posts 6193
Boards Moderated 0
Alias Born 05/01/2011

Re: None

Thursday, 03/23/2023 8:00:49 PM

Thursday, March 23, 2023 8:00:49 PM

Post# of 423948
If Amarin loses its appeal it means that the concept of "skinny labeling" is complete nonsense.

If generics can use skinny labeling to openly market a generic against all indications, patented or not, then what these Circuit f*cks are really saying is, "We don't give a shit how the law was crafted. Once the camel gets his nose under the tent, he gets to come the whole way in. Period."

We know f*cks like Dyk believe that. Hopefully we don't have to see his dickface again.

"The biggest obstacles to our progress exist within our own lives in the form of cowardice and the tendency to give up. Breaking through these barriers will unleash a surging wave of change." -- Daisaku Ikeda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News